INVESTMENT IN IMAGION BIOSYSTEMS

6 Months Ended

Jun. 30, 2019

INVESTMENT IN IMAGION BIOSYSTEMS

NOTE 3 - INVESTMENT IN IMAGION BIOSYSTEMS

As of June 30, 2019, the Company owns 64,099,476 shares of Imagion Biosystems (Imagion), resulting in a noncontrolling interest of Imagions issued and outstanding common stock. Initially, the Company held approximately 31% of Imagions total issued and outstanding common stock and was later was decreased to approximately 19%. Based upon Imagions trading price on June 30, 2019, approximately $0.011222 per share, the fair value of the Imagion shares was approximately $720,000. During the six months ended June 30, 2019, the Company recorded unrealized losses in its investment of $633,000.